Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus P Hoeflich

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
The International Journal of Biochemistry & Cell Biology|August 18, 2004
Radixin: cytoskeletal adopter and signaling proteinKlaus P Hoeflich, Mitsuhiko Ikura
Cell|April 17, 2002
Calmodulin in action: diversity in target recognition and activation mechanismsKlaus P Hoeflich, Mitsuhiko Ikura
Nature Reviews. Drug Discovery|April 28, 2026
Contemporary design of small-molecule kinase modulators: orthosteric, allosteric and induced-proximity strategiesJoachim Rudolph, Klaus P Hoeflich, Arvin C Dar
Expert Opinion on Therapeutic Patents|March 13, 2012
p21-Activated kinase inhibitors: a patent reviewJames J Crawford, Klaus P Hoeflich, Joachim Rudolph
Journal of Medicinal Chemistry|November 22, 2014
Inhibitors of p21-activated kinases (PAKs)Joachim Rudolph, James J Crawford, Klaus P Hoeflich, et al.
Methods in Enzymology|April 1, 2008
Inducible BRAF suppression models for melanoma tumorigenesisKlaus P Hoeflich, Bijay Jaiswal, David P Davis, et al.
The Enzymes|July 19, 2014
p21-activated kinase inhibitorsJoachim Rudolph, James J Crawford, Klaus P Hoeflich, et al.
The Journal of Clinical Investigation|May 2, 2015
Targeting cancer with kinase inhibitorsStefan Gross, Rami Rahal, Nicolas Stransky, et al.
Gut|November 26, 2010
Ascl2 and 11p15.5 amplification in colorectal cancerAdrian M Jubb, Klaus P Hoeflich, Peter M Haverty, et al.
Molecular Cell|October 29, 2003
MazF cleaves cellular mRNAs specifically at ACA to block protein synthesis in Escherichia coliYonglong Zhang, Junjie Zhang, Klaus P Hoeflich, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
The International Journal of Biochemistry & Cell Biology|August 18, 2004
Radixin: cytoskeletal adopter and signaling proteinKlaus P Hoeflich, Mitsuhiko Ikura
Cell|April 17, 2002
Calmodulin in action: diversity in target recognition and activation mechanismsKlaus P Hoeflich, Mitsuhiko Ikura
Nature Reviews. Drug Discovery|April 28, 2026
Contemporary design of small-molecule kinase modulators: orthosteric, allosteric and induced-proximity strategiesJoachim Rudolph, Klaus P Hoeflich, Arvin C Dar
Expert Opinion on Therapeutic Patents|March 13, 2012
p21-Activated kinase inhibitors: a patent reviewJames J Crawford, Klaus P Hoeflich, Joachim Rudolph
Journal of Medicinal Chemistry|November 22, 2014
Inhibitors of p21-activated kinases (PAKs)Joachim Rudolph, James J Crawford, Klaus P Hoeflich, et al.
Methods in Enzymology|April 1, 2008
Inducible BRAF suppression models for melanoma tumorigenesisKlaus P Hoeflich, Bijay Jaiswal, David P Davis, et al.
The Enzymes|July 19, 2014
p21-activated kinase inhibitorsJoachim Rudolph, James J Crawford, Klaus P Hoeflich, et al.
The Journal of Clinical Investigation|May 2, 2015
Targeting cancer with kinase inhibitorsStefan Gross, Rami Rahal, Nicolas Stransky, et al.
Gut|November 26, 2010
Ascl2 and 11p15.5 amplification in colorectal cancerAdrian M Jubb, Klaus P Hoeflich, Peter M Haverty, et al.
Molecular Cell|October 29, 2003
MazF cleaves cellular mRNAs specifically at ACA to block protein synthesis in Escherichia coliYonglong Zhang, Junjie Zhang, Klaus P Hoeflich, et al.
Pageof 7